This general notice is for all our patients, whether or not you come to us for pain or movement concerns.
On 14 September 2026, the Therapeutic Goods Administration published a decision to remove Andrographis from the list of ingredients permitted in listed medicines. The change took effect on 17 September. The TGA states the decision relates to allergy risk. It followed a consultation run earlier in 2026, and the TGA released information about existing products on 21 September.
Metagenics, whose products are sold through our clinic group's Healthy Market, stopped supplying its Andrographis-containing products at 5pm AEST on Friday 25 September 2026. These are:
Metagenics Immune Active NK; and Metagenics Gut InflamX.
People managing ongoing pain often take several products at once, including medicines from a doctor and supplements bought elsewhere. If you have one of the products above, speak with a practitioner, GP or pharmacist before taking more, and make sure every professional caring for you knows your full list. Signs such as a rash, facial swelling or wheezing after a herbal product need prompt medical attention.
Full details are published on the TGA website.
At your next appointment, please bring a list of everything you take so we can keep your records accurate.
Copyright© 2002-2026 visuallink© SaaS - Web Hosted Solutions, Design and Maintenance by Visual Link IT Pty Ltd - Software Solutions
Comments are disabled